Microbix Biosystems Inc. (TSX: MBX)
Canada
· Delayed Price · Currency is CAD 0.335
+0.010 (3.08%)
Jul 19, 2024, 1:35 PM EDT
Microbix Biosystems Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Year Ending | TTM | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Net Income | 4.06 | -0.04 | 1.79 | 3.23 | -6.23 | 0.03 | Upgrade
|
| Depreciation & Amortization | 1.02 | 1 | 0.88 | 0.67 | 0.55 | 0.43 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.18 | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Depreciation & Amortization, Total | 1.19 | 1.02 | 0.9 | 0.68 | 0.55 | 0.43 | Upgrade
|
| Other Amortization | 0.21 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | Upgrade
|
| Asset Writedown & Restructuring Costs | -3.08 | -3.08 | - | - | 3.08 | - | Upgrade
|
| Stock-Based Compensation | 0.76 | 0.74 | 0.65 | 0.38 | 0.16 | 0.15 | Upgrade
|
| Other Operating Activities | 0.41 | 0.35 | 0.33 | 0.89 | 1.85 | 0.22 | Upgrade
|
| Change in Accounts Receivable | -1.28 | -1.06 | 1.12 | -2.3 | -0.17 | -0.4 | Upgrade
|
| Change in Inventory | 0.7 | -0.47 | -0.88 | -0.11 | 0.19 | -0.03 | Upgrade
|
| Change in Accounts Payable | 0.3 | 0.25 | -0.22 | 0.18 | 0.02 | -0.3 | Upgrade
|
| Change in Unearned Revenue | 0.13 | 1.22 | -0.31 | -0.69 | 0.49 | -0.29 | Upgrade
|
| Change in Other Net Operating Assets | -0.53 | -0.14 | -0.05 | -0.27 | -0.12 | 0.07 | Upgrade
|
| Operating Cash Flow | 2.85 | -1.09 | 3.47 | 2.11 | 0.01 | 0.04 | Upgrade
|
| Operating Cash Flow Growth | 162.68% | - | 64.48% | 24494.16% | -80.69% | - | Upgrade
|
| Capital Expenditures | -1.01 | -1.02 | -2.03 | -1.24 | -0.81 | -0.43 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.06 | -0 | -0.08 | Upgrade
|
| Other Investing Activities | - | - | - | 0.68 | - | - | Upgrade
|
| Investing Cash Flow | -1.01 | -1.02 | -2.03 | -0.62 | -0.81 | -0.51 | Upgrade
|
| Long-Term Debt Issued | - | 1.54 | 1.07 | 0.63 | 0.74 | 1.14 | Upgrade
|
| Total Debt Issued | 0.03 | 1.54 | 1.07 | 0.63 | 0.74 | 1.14 | Upgrade
|
| Long-Term Debt Repaid | - | -0.3 | -2.45 | -0.55 | -2.09 | -0.62 | Upgrade
|
| Total Debt Repaid | -0.29 | -0.3 | -2.45 | -0.55 | -2.09 | -0.62 | Upgrade
|
| Net Debt Issued (Repaid) | -0.26 | 1.24 | -1.38 | 0.08 | -1.35 | 0.52 | Upgrade
|
| Issuance of Common Stock | 0.37 | 0.11 | 3.44 | 9.09 | 2.36 | - | Upgrade
|
| Repurchase of Common Stock | -0.8 | -1.12 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -0.77 | -0.21 | - | Upgrade
|
| Financing Cash Flow | -0.69 | 0.23 | 2.06 | 8.41 | 0.8 | 0.52 | Upgrade
|
| Net Cash Flow | 1.15 | -1.88 | 3.5 | 9.89 | -0 | 0.05 | Upgrade
|
| Free Cash Flow | 1.85 | -2.11 | 1.44 | 0.86 | -0.8 | -0.39 | Upgrade
|
| Free Cash Flow Growth | - | - | 66.64% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 7.74% | -12.78% | 7.55% | 4.65% | -7.64% | -2.90% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.02 | 0.01 | 0.01 | -0.01 | -0.00 | Upgrade
|
| Levered Free Cash Flow | 0.39 | -1.43 | 0.81 | -1.06 | -0.3 | -0.7 | Upgrade
|
| Unlevered Free Cash Flow | 0.96 | -0.91 | 1.33 | -0.05 | 0.36 | -0.03 | Upgrade
|
| Change in Net Working Capital | 1.06 | 0.07 | -0.03 | 2.97 | -0.66 | 0.93 | Upgrade
|
Source: S&P Capital IQ. Standard template.